Farallon Capital Management’s Blueprint Medicines BPMC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-4,000
| Closed | -$354K | – | 141 |
|
|
2025
Q1 | $354K | Hold |
4,000
| – | – | ﹤0.01% | 97 |
|
|
2024
Q4 | $349K | Hold |
4,000
| – | – | ﹤0.01% | 99 |
|
|
2024
Q3 | $370K | Hold |
4,000
| – | – | ﹤0.01% | 107 |
|
|
2024
Q2 | $431K | Hold |
4,000
| – | – | ﹤0.01% | 106 |
|
|
2024
Q1 | $379K | Hold |
4,000
| – | – | ﹤0.01% | 123 |
|
|
2023
Q4 | $369K | Hold |
4,000
| – | – | ﹤0.01% | 114 |
|
|
2023
Q3 | $201K | Sell |
4,000
-18,420
| -82% | -$925K | ﹤0.01% | 128 |
|
|
2023
Q2 | $1.42M | Hold |
22,420
| – | – | 0.01% | 119 |
|
|
2023
Q1 | $1.01M | Sell |
22,420
-71,580
| -76% | -$3.22M | 0.01% | 139 |
|
|
2022
Q4 | $4.12M | Buy |
+94,000
| New | +$4.12M | 0.02% | 152 |
|
|
2022
Q3 | – | Sell |
-1,211,987
| Closed | -$61.2M | – | 311 |
|
|
2022
Q2 | $61.2M | Sell |
1,211,987
-145,000
| -11% | -$7.32M | 0.33% | 66 |
|
|
2022
Q1 | $86.7M | Buy |
1,356,987
+545,240
| +67% | +$34.8M | 0.42% | 52 |
|
|
2021
Q4 | $86.9M | Sell |
811,747
-132,656
| -14% | -$14.2M | 0.43% | 49 |
|
|
2021
Q3 | $97.1M | Sell |
944,403
-180,597
| -16% | -$18.6M | 0.45% | 54 |
|
|
2021
Q2 | $99M | Buy |
1,125,000
+430,209
| +62% | +$37.8M | 0.4% | 51 |
|
|
2021
Q1 | $67.6M | Buy |
+694,791
| New | +$67.6M | 0.34% | 59 |
|